Seres Therapeutics MCRB
NASDAQ MCRB
$2.33 +0.02 (+0.87%)
As of: Oct 21, 2026 · 2:18 PM EDT

Seres Therapeutics (MCRB) Work In Process (2023 - 2024)

Updated

Seres Therapeutics (MCRB) reported Work In Process of $48.06 million for Q2 2024, up 911.9% from $4.75 million a year earlier and up 29.0% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Work In Process (2023 - 2024) Analysis & Trends

At the end of FY2023, Seres Therapeutics posted Work In Process of $25.22 million.

  • Per Business Quant data, the three quarters before Q2 2024 came in at $37.27 million (Q1 2024), $25.22 million (Q4 2023) and $14.99 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Seres Therapeutics 22.62 Mn -116.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 48.06 Mn
Mar 31, 2024 37.27 Mn
Dec 31, 2023 25.22 Mn
Sep 30, 2023 14.99 Mn
Jun 30, 2023 4.75 Mn
API Access

Seres Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=MCRB&period=max&api_key=YOUR_API_KEY